跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambroxed - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambroxed
Approved
STANDARD
Ambroxed
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ea9720c8d10661d1
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
ea9720c8d10661d1
Drug Approval Philippines Name
Ambroxed
Product Name
Ambroxed
Registration Number
DRP-6732-01
Brand Name
Ambroxed
Generic Name
Ambroxol Hydrochloride
Dosage Form
Extended Release Capsule
Dosage Strength
75 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
777 Red Pharma Inc.
Issuance Date
29 April 2021
Expiry Date
22 June 2026
Pharmacologic Category
Mucolytic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ea9720c8d10661d1
Type
Standard
Back to Philippines FDA Approvals